Medicared For All Logo

Christopher Orendorff in Sallisaw, Oklahoma

Home Oklahoma Sallisaw

Christopher Orendorff has Family Practice as his primary medical specialty. Their primary office is: 213 E Redwood Ave in Sallisaw, Oklahoma. There is an additional office location, for a total of two, for Christopher Orendorff that can be viewed further down.

They're a part of the: Sequoyah County City Of Sallisaw Hospital Authority medical group which has around 23 members. You can call their office at 918-1100 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Oklahoma College Of Medicine and graduated in 2009 (around 15 years of experience). They are listed as doing telehealth appointments.


Christopher W Orendorff Office Phone and Directions

Christopher Orendorff
Sequoyah County City Of Sallisaw Hospital Authority
213 E Redwood Ave
Sallisaw, Oklahoma 74955
918-1100


Patient Ratings
Please rate your experience with Christopher Orendorff below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 918-1100


Enter a starting address:


Healthcare Info for Christopher Orendorff

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: University Of Oklahoma College Of Medicine
Graduation Year: 2009
The Primary Medical Specialty for Christopher Orendorff is listed as: Family Practice
Approximate Years of Experience: 15
PAC (PECOS ID)#: 0648468405
NPI #: 1922233618
NPI Created On: 05/25/2009
NPI Last Updated Listed as: 09/29/2021
Primary Taxonomy Code: 207Q00000X
License Number:
27780
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • USAble Mutual Insurance Company
  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Destruction of skin growth
  2. Aspiration and/or injection of large joint or joint capsule
  3. Urinalysis, manual test
  4. Detection test for influenza virus
  5. Vaccine for influenza for administration into muscle, 0.5 ml dosage
  6. Routine ekg using at least 12 leads including interpretation and report
  7. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  8. New patient office or other outpatient visit, typically 30 minutes
  9. New patient office or other outpatient visit, typically 45 minutes
  10. Established patient office or other outpatient visit, typically 15 minutes
  11. Established patient office or other outpatient, visit typically 25 minutes
  12. Hospital observation care on day of discharge
  13. Hospital observation care, typically 50 minutes
  14. Initial hospital inpatient care, typically 50 minutes per day
  15. Initial hospital inpatient care, typically 70 minutes per day
  16. Subsequent observation care, typically 25 minutes per day
  17. Subsequent hospital inpatient care, typically 25 minutes per day
  18. Hospital observation or inpatient care moderate severity, 50 minutes per day'
  19. Hospital discharge day management, 30 minutes or less
  20. Hospital discharge day management, more than 30 minutes

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788827057

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788827059

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788827061

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788827063

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788827065

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788827067

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788827069

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $4

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795438439

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: UBRELVY

Open Associated Drug #1: 0023-6501-10


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795438421

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: UBRELVY

Open Associated Drug #1: 0023-6501-10


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795438427

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: UBRELVY

Open Associated Drug #1: 0023-6501-10


Additional Office Locations

1. Christopher W Orendorff Md Pc
1109 E Cherokee Ave
Sallisaw, OK 74955
Premier Primary Care
Group Members: 4

Phone: 918-1100

Enter a starting address:


Family Practice Professionals in Sallisaw

219 E Choctaw Ave
Sallisaw, OK
Lotus Medical Llc

301 S J T Stites St
Sallisaw, OK
Cherokee Nation

301 S J T Stites St
Sallisaw, OK
Cherokee Nation

301 S J T Stites St
Sallisaw, OK
Cherokee Nation

301 S J T Stites St
Sallisaw, OK
Cherokee Nation

1630 S Kerr Blvd
Sallisaw, OK
Stigler Health And Wellness Center Inc

Providers in Sequoyah County City Of Sallisaw Hospital Authority

1.Joshua Baker

213 E Redwood Ave
Sallisaw Ok 74955-2811
Sequoyah County City Of Sallisaw Hospital Authority
Emergency Medicine

2.Charlotte Barrett

213 E Redwood Ave
Sallisaw Ok 74955-2811
Sequoyah County City Of Sallisaw Hospital Authority
Nurse Practitioner

3.Michelle Bates

213 E Redwood Ave
Sallisaw Ok 74955-2811
Sequoyah County City Of Sallisaw Hospital Authority
Emergency Medicine

4.Jennifer Briggs

213 E Redwood Ave
Sallisaw Ok 74955-2811
Sequoyah County City Of Sallisaw Hospital Authority
Emergency Medicine

5.Jamin Brown

213 E Redwood Ave
Sallisaw Ok 74955-2811
Sequoyah County City Of Sallisaw Hospital Authority
Emergency Medicine

6.Jack Casas Md

213 E Redwood Ave
Sallisaw Ok 74955-2811
Sequoyah County City Of Sallisaw Hospital Authority
Interventional Cardiology

View all 23 members of Sequoyah County City Of Sallisaw Hospital Authority medical group